Oren Ilan (CIK 1643073) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy ROIV (5,054 shares), Sell ROIV (2,378 shares), Buy ROIV (775 shares), Buy ROIV (896 shares), Sell ROIV (95 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 5,054 | $0 |
| 2026-09-14 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 2,378 | $97,355 |
| 2026-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 775 | $0 |
| 2026-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 896 | $0 |
| 2026-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 95 | $2,834 |
| 2026-01-22 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,164 | $0 |
| 2026-01-22 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 124 | $2,850 |
| 2025-10-22 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,507 | $0 |
| 2025-10-22 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 281 | $4,985 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 14,524 | $0 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 2,043 | $28,132 |
| 2025-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 2,296 | $0 |
| 2025-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 115 | $1,340 |
| 2025-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 2,635 | $0 |
| 2025-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 64 | $650 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18